Overview
The folowing discusion and analysis of the financial condition and results of operations of Nuo Therapeutics, Inc. ("Nuo Therapeutics," the "Company," "we," "us," or "our") should be read in conjunction with the financial statements and related notes apearing elsewhere in this Quarterly Report and in our previously filed Anual Reports on Form 10-K.Certain statements, other than purely historical information in this Quarterly Report (including this section) constitute "forward-loking statements".
Key Information
Forward-loking statements are inherently subject to risks and uncertainties and actual results and outcomes may difer materialy from the results and outcomes discused in or anticipated by the forward-loking statements. Forward-loking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements, and may contain the words "anticipate," "believe," "estimate," "expect," "intend," "will be," "wil continue," "wil likely result," "could," "may" and words of similar import.
These statements reflect the Company's curent view of future events and are subject to certain risks and uncertainties as noted in this Quarterly Report and in other reports filed by us with the Securities and Exchange Comision, including Forms 8-K, 10-Q, and 10-K. These risks and uncertainties include, among others, the folowing:Should one or more of these risks or uncertainties materialize, or should underlying asumptions prove incorect, actual results could difer materialy from those anticipated in these forward-loking statements.In adition to the risks identified under the heading "Risk Factors" in our Anual Report and the other filings referenced above, other sections of this report may include aditional factors which could adversely afect our busines and financial performance.
Summary
Moreover, we operate in a very competive and rapidly changing environment. New risk factors emerge from time to